Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

UVA Labeling Scaled Rating System Recommended By Schering Exec

This article was originally published in The Tan Sheet

Executive Summary

UVA sunscreen labeling based on "minimum" to "maximum" designations depending on the level of UVA protection offered by a product was proposed by Schering-Plough Research Director-Photobiology Patricia Agin, PhD, at the American Academy of Dermatology's UVA consensus conference in Washington, D.C. Feb. 4.

You may also be interested in...



UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey

Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.

UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey

Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.

UVA Protection Provided By 10% Of Sunscreens Tested - Researcher Diffey

Only six of 59 commercially available sunscreens met the critical wavelength standard of +/-370 nm to establish efficacy against UVA light, Brian Diffey, Newcastle General Hospital, England, et al., determine in a study published in the December Journal of the American Academy of Dermatology.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090871

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel